{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T16:12:06Z","timestamp":1773677526390,"version":"3.50.1"},"reference-count":30,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Breast cancer is the most common malignancy in women, and sentinel lymph node (SLN) biopsy is essential for accurate nodal staging while avoiding unnecessary axillary dissection. Aim: This study aimed to compare SLN detection rates between two dual-tracer techniques: indocyanine green plus patent blue (ICG + PB) and technetium-99m plus patent blue (99mTc + PB), and to identify factors associated with detection failure for each tracer. Methods: All clinically node-negative breast cancer patients undergoing SLN biopsy between January 2014 and December 2024 were retrospectively evaluated. SLN detection was considered successful when at least one node was identified intraoperatively and confirmed histologically. Multivariate analysis assessed clinical and tumor-related predictors of failure. Results: A total of 269 procedures (258 patients) were analyzed, including 152 ICG + PB and 117 99mTc + PB procedures. Detection rates were comparable between groups (95.4% vs. 94.9%, p = 0.96), with no significant differences in the number of SLNs retrieved or nodal positivity. Multivariate analysis identified increasing patient age as the only independent predictor of PB failure, while no variables were associated with ICG failure. Tumor location in the upper-inner quadrant was the sole predictor of 99mTc failure. Conclusions: ICG + PB and 99mTc + PB provide equivalent and high SLN detection rates. ICG appears to be a robust, radiation-free alternative with no identifiable predictors of failure, supporting its role as an effective mapping strategy, particularly in centers aiming to optimize workflow and patient safety, despite the limited available data on its efficacy.<\/jats:p>","DOI":"10.3390\/cancers18060959","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T14:30:32Z","timestamp":1773671432000},"page":"959","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative Evaluation of Sentinel Lymph Node Detection Rates in Breast Cancer Surgery: \u201cICG + Patent Blue\u201d Versus \u201c99mTc + Patent Blue\u201d, a 11-Year Single-Center Study"],"prefix":"10.3390","volume":"18","author":[{"given":"Ines","family":"Hfaiedh","sequence":"first","affiliation":[{"name":"University Hospital of Fribourg, H\u00f4pital Fribourgeois (HFR), 1752 Fribourg, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8958-6049","authenticated-orcid":false,"given":"Arrigo","family":"Fruscalzo","sequence":"additional","affiliation":[{"name":"University Hospital of Fribourg, H\u00f4pital Fribourgeois (HFR), 1752 Fribourg, Switzerland"},{"name":"Department of Medicine, Faculty of Science and Medicine, University of Fribourg, 1700 Fribourg, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joy Shannon","family":"Sudan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Science and Medicine, University of Fribourg, 1700 Fribourg, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9817-9445","authenticated-orcid":false,"given":"Anis","family":"Feki","sequence":"additional","affiliation":[{"name":"University Hospital of Fribourg, H\u00f4pital Fribourgeois (HFR), 1752 Fribourg, Switzerland"},{"name":"Department of Medicine, Faculty of Science and Medicine, University of Fribourg, 1700 Fribourg, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4498-3734","authenticated-orcid":false,"given":"Benedetta","family":"Guani","sequence":"additional","affiliation":[{"name":"University Hospital of Fribourg, H\u00f4pital Fribourgeois (HFR), 1752 Fribourg, Switzerland"},{"name":"Department of Medicine, Faculty of Science and Medicine, University of Fribourg, 1700 Fribourg, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1200\/JCO.21.00934","article-title":"Management of the axilla in early-stage breast cancer: Ontario Health (Cancer Care Ontario) and ASCO guideline","volume":"39","author":"Brackstone","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"6520","DOI":"10.1245\/s10434-023-13824-6","article-title":"Novel dual tracer indocyanine green and radioisotope versus gold standard sentinel lymph node biopsy in breast cancer: The GREENORBLUE trial","volume":"30","author":"Nguyen","year":"2023","journal-title":"Ann. Surg. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10549-025-07767-7","article-title":"The use of indocyanine green and technetium-99 for dual-tracer sentinel lymph node biopsy in breast cancer","volume":"213","author":"Kolbow","year":"2025","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Da Silva S\u00e1, R., Von Ah Rodrigues, R.F., Bugalho, L.A., Da Silva, S.U., and Naz\u00e1rio, A.C.P. (2023). Evaluation of the efficacy of using indocyanine green associated with fluorescence in sentinel lymph node biopsy. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0273886"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): A prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"8848","DOI":"10.1245\/s10434-024-16176-x","article-title":"Results of a prospective randomized multicenter study comparing indocyanine green (ICG) fluorescence combined with a standard tracer versus ICG alone for sentinel lymph node biopsy in early breast cancer: The INFLUENCE trial","volume":"31","author":"Pitsinis","year":"2024","journal-title":"Ann. Surg. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Pinelli, M., Gerardi, C., Lettieri, E., Maioru, M., Marone, L., Bertoldi, L., Navanteri, G., Costantini, M., Botti, C., and Pellini, F. (2024). Comparison of indocyanine green with conventional tracers for sentinel lymph node biopsy in breast cancer: A multidisciplinary evaluation of clinical effectiveness, safety, organizational and economic impact. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0309336"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1245\/s10434-020-09288-7","article-title":"Meta-analysis comparing fluorescence imaging with radioisotope and blue dye-guided sentinel node identification for breast cancer surgery","volume":"28","author":"Kedrzycki","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/6251468","article-title":"Sentinel lymph node biopsy in breast cancer patients by means of indocyanine green using the Karl Storz VITOM\u00ae fluorescence camera","volume":"2018","author":"Papathemelis","year":"2018","journal-title":"BioMed Res. Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.clbc.2025.12.005","article-title":"Cost analysis of technetium-99m versus indocyanine green for sentinel lymph node biopsy in breast cancer","volume":"26","author":"Boyanova","year":"2026","journal-title":"Clin. Breast Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/SLA.0000000000005633","article-title":"Sentinel lymph node mapping in breast cancer patients through fluorescent imaging using indocyanine green: The INFLUENCE trial","volume":"276","author":"Bargon","year":"2022","journal-title":"Ann. Surg."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jamcollsurg.2018.12.001","article-title":"Near infrared fluorescent lymph node mapping with indocyanine green in breast cancer patients: A prospective trial","volume":"228","author":"Valente","year":"2019","journal-title":"J. Am. Coll. Surg."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1245\/s10434-021-11255-9","article-title":"A prospective study evaluating the accuracy of indocyanine green (ICG) fluorescence compared with radioisotope for sentinel lymph node (SLN) detection in early breast cancer","volume":"29","author":"Dumitru","year":"2022","journal-title":"Ann. Surg. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13017-025-00575-w","article-title":"Indocyanine green fluorescence-guided surgery in the emergency setting: The WSES international consensus position paper","volume":"20","author":"Boni","year":"2025","journal-title":"World J. Emerg. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00404-025-08244-8","article-title":"Safety of indocyanine green for lymph node mapping in early-stage vulvar cancer: Multicenter evaluation and systematic review","volume":"313","author":"Couso","year":"2026","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e70274","DOI":"10.1002\/cncr.70274","article-title":"Indocyanine green assists with sentinel lymph node mapping in pediatric and adolescent patients: A Pediatric Surgical Oncology Research Collaborative prospective observational study","volume":"132","author":"Schermerhorn","year":"2026","journal-title":"Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e430","DOI":"10.1016\/S1470-2045(16)30311-4","article-title":"De-escalation of axillary surgery in early breast cancer","volume":"17","author":"Jatoi","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"21366","DOI":"10.1038\/s41598-025-06338-6","article-title":"Robot assisted sentinel lymph node biopsy using indocyanine green combined with carbon nanoparticles staining improved detection rates in breast cancer","volume":"15","author":"Wang","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e42500","DOI":"10.1097\/MD.0000000000042500","article-title":"Assessing the benefit of using indocyanine green in addition to methylene blue for breast cancer sentinel lymph node biopsy","volume":"104","author":"Meng","year":"2025","journal-title":"Medicine"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1111\/tbj.14100","article-title":"Indocyanine green for sentinel lymph node detection in early breast cancer: Prospective evaluation of detection rate and toxicity\u2014The FLUOBREAST trial","volume":"26","author":"Sharifzadehgan","year":"2020","journal-title":"Breast J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1016\/S1470-2045(13)70590-4","article-title":"Novel techniques for sentinel lymph node biopsy in breast cancer: A systematic review","volume":"15","author":"Ahmed","year":"2014","journal-title":"Lancet Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"6943","DOI":"10.1038\/s41598-019-43473-3","article-title":"Randomized comparison between indocyanine green fluorescence plus 99mtechnetium and 99mtechnetium alone methods for sentinel lymph node biopsy in breast cancer","volume":"9","author":"Vermersch","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/MNM.0000000000000971","article-title":"Predictive risk factors for sentinel lymph node nonvisualization on planar lymphoscintigraphy using an intratumoral injection in patients with primary breast cancer","volume":"40","author":"Hellingman","year":"2019","journal-title":"Nucl. Med. Commun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/MNM.0b013e328361cd84","article-title":"Prevalence and risk factors of intraoperative identification failure of sentinel lymph nodes in patients affected by breast cancer","volume":"34","author":"Bernardi","year":"2013","journal-title":"Nucl. Med. Commun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/SLA.0000000000000551","article-title":"Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance)","volume":"261","author":"Boughey","year":"2015","journal-title":"Ann. Surg."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijsu.2016.08.002","article-title":"Limited effectiveness of patent blue dye in addition to isotope scanning for identification of sentinel lymph nodes: Cross-sectional real-life study in 1024 breast cancer patients","volume":"33","author":"Rauch","year":"2016","journal-title":"Int. J. Surg."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s10549-025-07608-7","article-title":"Sentinel lymph node biopsy in breast cancer: The role of ICG fluorescence after neoadjuvant chemotherapy","volume":"210","author":"Bogacz","year":"2025","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ajog.2025.04.052","article-title":"Assessing the comparative efficacy of sentinel lymph node detection techniques in vulvar cancer: A systematic review and meta-analysis","volume":"233","author":"Vida","year":"2025","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/wjs.70231","article-title":"Evaluating single agent indocyanine green as an alternative to dual dye-tracer mapping in sentinel lymph node biopsy for breast cancer: A two-arm open-label randomized controlled trial","volume":"50","author":"Chandra","year":"2026","journal-title":"World J. Surg."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1007\/s00268-023-07036-y","article-title":"Evaluation of dual dye technique for sentinel lymph node biopsy in breast cancer: Two-arm open-label parallel design non-inferiority randomized controlled trial","volume":"47","author":"Suhani","year":"2023","journal-title":"World J. Surg."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/6\/959\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T14:40:53Z","timestamp":1773672053000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/6\/959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["cancers18060959"],"URL":"https:\/\/doi.org\/10.3390\/cancers18060959","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]}}}